Alum Or Burnt Alum Patents (Class 424/698)
  • Publication number: 20140294995
    Abstract: The present invention relates to a pharmaceutical formulation containing a combination of (a) at least one astringent active substance and (b) at least one mucilaginous drug and the use thereof for the prevention or treatment of inflammatory diseases of the oropharyngeal region and for the treatment of painful irritations of the mucosa in the oropharyngeal region and associated irritable cough.
    Type: Application
    Filed: April 1, 2014
    Publication date: October 2, 2014
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Julia BONI, Bernd PLOHMANN, Sandra SAUERLAND
  • Patent number: 8821904
    Abstract: A topical composition and its use for the prophylaxis and the treatment of defects connected to inflammatory dermopathies. Particularly, a topical composition including at least an alum, 18-?-glycyrrhetic acid and/or one derivative thereof, and vitamin A and/or one derivative thereof, and the use of such composition for the prophylaxis and the treatment of inflammatory dermopathies, preferably of the seborrhoeic dermatitis and of those affections in which the presence of an excess of sebum occurs.
    Type: Grant
    Filed: May 4, 2011
    Date of Patent: September 2, 2014
    Assignee: Skinius S.R.L.
    Inventor: Antonino Di Pietro
  • Publication number: 20140161903
    Abstract: The invention features topical formulations comprising an osmotically active agent and/or a vasoconstrictor and/or an astringent agent for the treatment and prevention of eyelid swelling, and methods of use thereof.
    Type: Application
    Filed: February 12, 2014
    Publication date: June 12, 2014
    Applicant: ACIEX THERAPEUTICS, INC.
    Inventors: Matthew J. Chapin, Mark Barry Abelson, Keith Jeffrey Lane, Akimitsu Makino
  • Patent number: 8741353
    Abstract: The ointment for healing burns and wounds includes a composition for treating skin burns, wounds, and other infection-prone skin complications. The composition includes honeycomb, sesame seed oil, myrrh, curcumin, mukul, and potassium alum. The ointment includes only natural ingredients that are unadulterated or minimally processed. Topical use of the ointment does not result in harmful side effects.
    Type: Grant
    Filed: January 27, 2014
    Date of Patent: June 3, 2014
    Inventor: May Ghaith M. Al-Mutawaa
  • Patent number: 8658193
    Abstract: Technologies are described herein for styptic compounds comprising a hemostatic or styptic agent suspended within a hydrophobic carrier medium. Example carrier mediums may include waxes, lipids, oils, or combinations thereof. The compound may be a semisolid at room temperature and soft enough to be easily dispensed and formed into or onto bleeding tissue of an animal or human. The hydrophobic qualities of the carrier medium can protect the styptic agent from absorbing moisture. The carrier medium can mechanically support positioning treatments adjacent to the bleeding tissue. The carrier medium can further serve to mechanically seal the tissue to aid in hemostasis while also protecting the tissue from debris and contamination. The carrier medium can aid in maintaining moisture within the tissue. Slurry-based manufacturing processes can support a substantially homogeneous dispersal of styptic agent throughout the carrier medium.
    Type: Grant
    Filed: June 8, 2012
    Date of Patent: February 25, 2014
    Inventor: Robert J. Greenwald
  • Publication number: 20140010896
    Abstract: In an embodiment of the present invention, a composition for removing a tick and providing relief therefrom comprises a solvent, a carrier fluid suitable for increasing the rate of seepage of the solvent into the host, a solubilizer suitable for increasing the solubility of the composition in water, and a solution that provides soothing and aids in healing the host.
    Type: Application
    Filed: July 9, 2013
    Publication date: January 9, 2014
    Inventor: Cynthia M. Chapman
  • Patent number: 8460642
    Abstract: The present invention provides a method of promoting bone growth in a subject in need thereof, by administering to the subject a therapeutically effective amount of a compound of Formula I. The present invention also provides methods for the treatment of renal disease and cancer.
    Type: Grant
    Filed: April 25, 2012
    Date of Patent: June 11, 2013
    Assignee: OssiFi, Inc.
    Inventors: Debra Ellies, William Rosenberg
  • Publication number: 20130101686
    Abstract: A topical composition and its use for the prophylaxis and the treatment of defects connected to inflammatory dermopathies. Particularly, a topical composition including at least an alum, 18-?-glycyrrhetic acid and/or one derivative thereof, and vitamin A and/or one derivative thereof, and the use of such composition for the prophylaxis and the treatment of inflammatory dermopathies, preferably of the seborrhoeic dermatitis and of those affections in which the presence of an excess of sebum occurs.
    Type: Application
    Filed: May 4, 2011
    Publication date: April 25, 2013
    Applicant: SKINIUS S.R.L.
    Inventor: Antonio DiPietro
  • Publication number: 20120253298
    Abstract: A tissue thickness compensator may generally comprise a first layer comprising a first medicament, a second layer comprising a second medicament, and a third layer comprising a third medicament. The tissue thickness compensator may comprise a first layer comprising a first medicament, a second layer comprising a second medicament, and a reservoir comprising a third medicament disposed within the reservoir. The medicaments may be independently selected from a haemostatic agent, an anti-inflammatory agent, an antibiotic agent, anti-microbial agent, an anti-adhesion agent, an anti-coagulant agent, a pharmaceutically active agent, a matrix metalloproteinase inhibitor, and combinations thereof. Articles of manufacture comprising the tissue thickness compensator and methods of making and using the tissue thickness compensator are also described.
    Type: Application
    Filed: March 28, 2012
    Publication date: October 4, 2012
    Applicant: Ethicon Endo-Surgery, Inc.
    Inventors: Cortney E. Henderson, Taylor W. Aronhalt, Chunlin Yang, Charles J. Scheib, Venkataramanan Mandakolathur Vasudevan, Mark D. Timmer, Richard W. Timm, Tamara Widenhouse, Steven G. Hall
  • Patent number: 8158159
    Abstract: A pharmaceutical formulation for treating tinea of feet and hands is disclosed, which is composed of Fructus Gleditsia, Alumen and Borneol. Also disclosed is a cream preparative method of the pharmaceutical formulation, which comprises Fructus Gleditsia is decocted with water, and the decocted liquid is dried under decompression into powder, which is formulated to a cream together with the powders of Alumen and Borneol as well as the respective excipients.
    Type: Grant
    Filed: February 12, 2007
    Date of Patent: April 17, 2012
    Assignee: Shen Zhen Bei Ke Lian Pharmaceutical Sci-Tech Co., Ltd.
    Inventor: Jinghua Chen
  • Patent number: 8003644
    Abstract: Biocidal compositions that contain biocidal components, such as an oxidant, and mixed with said components a combination of inorganic compounds capable of reducing the oxidative capacity of the biocidal components by forming a low-melting glass when heated. The biocidal composition may be heated by being ignited or subjected to a heating source, such as a fire.
    Type: Grant
    Filed: April 8, 2004
    Date of Patent: August 23, 2011
    Assignee: Bromine Compounds Ltd.
    Inventor: Theodor Morel Fishler
  • Patent number: 7850973
    Abstract: The invention provides compositions and methods for the treatment of diseases associated with amyloid deposits of A? in the brain of a patient, such as Alzheimer's disease. Such methods entail administering an immunogenic fragment of A?, lacking a T-cell epitope, capable of inducing a beneficial immune response in the form of antibodies to A?. In another aspect, the immunogenic fragment of A? is capable of elevating plasma A? levels. The immunogenic fragments comprise linear or multivalent peptides of A?. Pharmaceutical compositions comprise the immunogenic fragment chemically linked to a carrier molecule which may be administered with an adjuvant.
    Type: Grant
    Filed: May 1, 2006
    Date of Patent: December 14, 2010
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Victor M. Garsky, Joseph G. Joyce, Paul M. Keller, Gene Kinney, Xiaoping Liang, John W. Shiver
  • Patent number: 7824686
    Abstract: The present invention is concerned with vaccines and their preparation. An effective long-term immune response, especially in mammals, can be produced using a vaccine comprising an antigen encapsulated in liposomes, a suitable adjuvant and a carrier comprising a continuous phase of a hydrophobic substance. The vaccine is particularly effective in eliciting the production of antibodies that recognize epitopes of native proteins.
    Type: Grant
    Filed: November 20, 2008
    Date of Patent: November 2, 2010
    Assignee: Immunovaccine Technologies, Inc.
    Inventors: Robert George Brown, Bill Pohajdak, Warwick Charles Kimmins
  • Patent number: 7811554
    Abstract: The horse liniment is a veterinary composition for topical application for the relief of muscle and joint pain in horses. The composition contains, by weight, about 49% alcohol, 20% olive oil, 10% arnica, 14% creosote, 1% iodine, 2% turpentine, 2% camphor, and 2% alum. The ingredients may be mixed at room temperature, the powdered ingredients being soluble in the alcohol-olive oil base. The composition is applied topically to the affected muscles or joints in conventional manner as needed. The composition has been found to be effective, often with a single application, with increased range of motion, an absence or reduction of limping, increased energy, and other signs of a healthy, active horse.
    Type: Grant
    Filed: January 18, 2008
    Date of Patent: October 12, 2010
    Inventor: Flavio Lozano
  • Publication number: 20100068306
    Abstract: An herbal composition capable of helping to speed the body's healing reaction to infection, and methods of treating wounds and infections using such a composition are provided.
    Type: Application
    Filed: September 14, 2009
    Publication date: March 18, 2010
    Inventor: Chin-Pao Chou
  • Patent number: 7597911
    Abstract: A selection of herbal materials with curative effects combined in a liquid form and processed into a suitable topical delivery system for application to skin ulcerations, surgical incisions wounds and cuts to accomplish accelerated wound healing. The present invention can also heal and provide 1st and 2nd degree burn, radiation burn and sunburn relief and be used for application to human skin affected with psoriasis, eczema, dermatitis, acne, rosacea, extreme dryness, allergic reactions and inflammatory rashes. The process to manufacture and the herbal extract vehicle of delivery are both critical to the effectiveness of the present invention since the invention is comprised of two separate herbal composition extracts which do not form a homogenous mixture when combined.
    Type: Grant
    Filed: August 16, 2002
    Date of Patent: October 6, 2009
    Assignee: CuraPharm, Inc.
    Inventor: Thomas M. Hnat
  • Patent number: 7560099
    Abstract: A fragrant, topical antiseptic, astringent mixture which eliminates the bumping caused by the use of a razor and/or a depilatory is provided. The aftershave composition includes aluminum potassium sulfate dodecahydrate and an aromatic oil in a 70% by volume solution of isopropyl alcohol.
    Type: Grant
    Filed: June 25, 2007
    Date of Patent: July 14, 2009
    Inventor: Donald D. Ramsey
  • Patent number: 7498037
    Abstract: The invention concerns novel Plasmodium falciparum antigens and their vaccine and diagnostic applications. More particularly, the invention concerns immunogenic polynucleotide and polypeptide molecules, compositions comprising them, and methods for diagnosis and vaccination of malaria.
    Type: Grant
    Filed: November 14, 2003
    Date of Patent: March 3, 2009
    Assignee: Institut Pasteur
    Inventors: Pierre Druilhe, Anne-Charlotte Grüner
  • Patent number: 7479282
    Abstract: This invention provides an isolated polypeptide comprising an amino acid sequence of a N-terminal choline binding protein A truncate in which the amino acid sequence is set forth in any of SEQ ID NOS: 1, 3-7, or 9-11, including fragments, mutants, variants, analogs, or derivatives, thereof. Also, this invention provides a isolated polypeptide comprising an amino acid sequence of a N-terminal choline binding protein A truncate, wherein the amino acid is set forth in SEQ ID NO: 24, wherein the polypeptide retains its native tertiary structure and methods of preparation. This invention provides an isolated polypeptide comprising an amino acid sequence of a N-terminal choline binding protein A truncate, wherein the polypeptide has lectin activity and does not bind to choline. This invention provides an isolated immunogenic polypeptide comprising an amino acid sequence of a N-terminal choline binding protein A truncate.
    Type: Grant
    Filed: January 5, 2004
    Date of Patent: January 20, 2009
    Assignees: St. Jude Children's Research Hospital, Medimmune
    Inventors: Elaine I. Tuomanen, Theresa M. Wizemann, H. Robert Masure, Leslie S. Johnson, Scott Koenig
  • Patent number: 7431936
    Abstract: The present invention provides the RSP-1 and RSP-2 proteins which are involved in the cytoadhesion of P. falciparum during ring-stage infection of erythrocytes, antibodies which bind to the proteins, methods of screening for a P. falciparum infection, methods of determining the infective stage of P. falciparum and vaccines for protecting individuals from Plasmodium sp. infections.
    Type: Grant
    Filed: November 29, 2002
    Date of Patent: October 7, 2008
    Assignees: Institut Pasteur, Centre National de la Recherche Scientifique
    Inventors: Juerg Gysin, Bruno Pouvelle, Artur Scherf, Pierre Buffet
  • Patent number: 7404960
    Abstract: A vaccine composition comprising two valences is provided: (i) a first valence which is adjuvant-enhanced with aluminum hydroxide and (ii) a second valence which contains a polysaccharide of bacterial capsule comprising one or more o-acetyl groups and which is not adsorbed with aluminum oxide due to the presence of a protecting compound which may be a phosphate, a citrate or a carbonate and which prevents the adsorption. The first valence can be any vaccine valence. In one particular embodiment, the vaccine composition contains (i) Hepatitis A valence, adsorbed on aluminum hydroxide and (ii) the typhoid fever valence formed by the polysaccharide Vi of the Salmonella typhi capsule.
    Type: Grant
    Filed: July 31, 2002
    Date of Patent: July 29, 2008
    Assignee: Aventis Pasteur SA
    Inventor: Alain Françon
  • Patent number: 7252843
    Abstract: A composition and method for cleaning, sanitizing and maintaining contained bodies of water such as swimming pools, wading pools, fountains, ornamental ponds, etc. The composition includes pre-determined percentages of copper sulfate, zinc sulfate, and aluminum sulfate by weight. The composition and method reduce amounts of chlorine and an amount of labor associated with the cleaning, sanitization and maintenance of contained bodies of water.
    Type: Grant
    Filed: December 13, 2004
    Date of Patent: August 7, 2007
    Inventors: David J. Moore, William C. Betts
  • Patent number: 7235266
    Abstract: Disclosed are a facial pack composition and a bathing composition based on loess, and methods for preparing the same. The bathing composition makes a user feel refreshed, prevents arteriosclerosis and fat accumulation in human bodies, is useful for the treatment of maturating diseases such as dermatophytosis and dermatitis and stimulates metabolism and blood circulation system of the human body. Additionally, the facial pack includes loess having a fine particle size sufficient to avoid skin irritation and thus does not adversely affect the skin even if the user uses the pack everyday. The loess is pretreated by a unique aging method and selected additives, so that the far infrared ray-emitting effect of the loess can be maximized. Therefore, it provides skin health-aid and cosmetic effects.
    Type: Grant
    Filed: January 9, 2006
    Date of Patent: June 26, 2007
    Inventor: Jang Yong Park
  • Patent number: 7029705
    Abstract: A method is disclosed of practicing nasal hygiene comprising the steps of applying to a person's nostril a non-irritating hygienic composition consisting essentially of a product of compounding under homogenizing conditions water, 0.01% to 5% by weight, as chlorine dioxide, of a source of chlorine dioxide; 0.01% to 3% by weight of at least one olfactory stimulant, 0 to 5% by weight of at least one fixative compound less volatile than the olfactory stimulant 0.1 to 2.5% by weight of at least one inorganic salt selected from the group consisting of alkali metal chloride, alkali metal bicarbonate, and alkali metal chlorate; and 0.0002 to 0.006% (as aluminum) by weight of at least one water soluble aluminum compound, provided that the total concentration of inorganic salt is in the range from 0.6% by weight to 2.5% by weight, holding the composition within the nostril for a hygienic holding period, and discharging the composition from the treated nostril.
    Type: Grant
    Filed: July 30, 2003
    Date of Patent: April 18, 2006
    Inventor: Allan H. Fuhr
  • Patent number: 7011824
    Abstract: A method of treating animal manure solids comprises contacting the solids with a treatment composition comprising AlCl3.nH2O or Al(NO3)3.mH2O, or the residue of AlCl3.nH2O or Al(NO3)3.mH2O, to form a treated waste product, wherein n is from 0 to 10, and m is from 0 to 12. The treatment amount can be effective to reduce phosphorus solubility in the manure; reduce phosphorus runoff and/or phosphorus leaching from fields fertilized with manure; inhibit ammonia volatilization from the manure; flocculate solids in the manure; reduce pathogens in the manure; increase the nitrogen content in the manure; and/or reduce acid rain and PM-10s associated with the manure.
    Type: Grant
    Filed: December 4, 2000
    Date of Patent: March 14, 2006
    Assignees: The United States of America as represented by the Secretary of Agriculture, The Board of Trustees of the University of Arkansas
    Inventor: Philip A. Moore, Jr.
  • Patent number: 6958159
    Abstract: The present invention relates to an improved pharmaceutical composition useful for the topical treatment of burns, cuts, wounds, abrasions and the like, and to methods of treatment of injured body surfaces such as skin.
    Type: Grant
    Filed: March 26, 2001
    Date of Patent: October 25, 2005
    Assignee: Chiltern Pharmaceuticals, Pty Ltd.
    Inventor: Robert Alan Smith
  • Patent number: 6951651
    Abstract: We have screened the HCMV-specific T cell clone, 33F4, with a nonamer PS-SCL based on SEQ ID NO: 1, and described a series of analog peptides that are recognized with greater affinity than the native peptide sequence.
    Type: Grant
    Filed: August 20, 2003
    Date of Patent: October 4, 2005
    Assignee: City of Hope
    Inventor: Don J. Diamond
  • Patent number: 6929800
    Abstract: A nasal passage cleaning composition according to the invention comprises water and salt as a base, and contains a mucolytic agent such as alum and/or zinc sulphate to shrink the mucosa and allow sinus passage drainage, decreasing pressure in the infected sinus an alleviates sinus headache and face ache. A preferred mucolytic agent is n-acetyl-L-cystine, which is used to dissolve or soften mucus in the nasal passages, though methyl salicylate may also be used to disintegrate crusted mucus, acting also as a topical anti-inflammatory agent and as a pain relieving agent to reduce pain and discomfort.
    Type: Grant
    Filed: August 6, 2001
    Date of Patent: August 16, 2005
    Inventor: Abdul Rasoul Salman
  • Patent number: 6793923
    Abstract: The present invention is concerned with vaccines and their preparation. An effective long-term immune response, especially in mammals, can be produced using a vaccine comprising an antigen encapsulated in liposomes, a suitable adjuvant and a carrier comprising a continuous phase of a hydrophobic substance. The vaccine is particularly effective in eliciting the production of antibodies that recognize epitopes of native proteins.
    Type: Grant
    Filed: November 6, 2001
    Date of Patent: September 21, 2004
    Assignee: Immunovaccine Technologies, Inc.
    Inventors: Robert George Brown, William Pohajdak, Warwick Charles Kimmins
  • Publication number: 20040175445
    Abstract: A selection of herbal materials with curative effects combined in a liquid form and processed into a suitable topical delivery system for application to skin ulcerations, surgical incisions wounds and cuts to accomplish accelerated wound healing. The present invention can also heal and provide 1st and 2nd degree burn, radiation burn and sunburn relief and be used for application to human skin affected with psoriasis, eczema, dermatitis, acne, rosacea, extreme dryness, allergic reactions and inflammatory rashes. The process to manufacture and the herbal extract vehicle of delivery are both critical to the effectiveness of the present invention since the invention is comprised of two separate herbal composition extracts which do not form a homogenous mixture when combined.
    Type: Application
    Filed: February 13, 2004
    Publication date: September 9, 2004
    Inventor: Thomas M. Hnat
  • Patent number: 6696065
    Abstract: A multi-component vaccine composition is described comprising acellular pertussis vaccine components, diphtheria toxoid, tetanus toxoid and inactivated poliovirus. The composition also may contain a conjugate of a capsular polysaccharide on Haemophilus influenzae type b and tetanus toxoid or diphtheria toxoid, which may be reconstituted from a lyophilized state by the other component. The administration of the multiple component vaccine resulted in no diminution of the immunogenicity of any component as a result of interference by other components of the vaccine.
    Type: Grant
    Filed: July 2, 1996
    Date of Patent: February 24, 2004
    Assignee: Aventis Pastuer Limited
    Inventors: Raafat E. F. Fahim, Larry U. L. Tan, Luis Barreto, John Thipphawong, Gail E. D. Jackson
  • Patent number: 6692775
    Abstract: A gel formulation is combined with a bactericidal concentrate which is a liquid mixture of about 1000 parts by volume of ultra pure water having an electrical resistance of 16-26 megohms, total dissolved solids of less than 0.04 parts per million and a specific conductance of less than 0.10 mho with about 1.2 to 3 parts by volume of Willard Water as prepared in accordance with U.S. Pat. No. 3,893,943. The bactericidal liquid concentrate in the amount of 3.5 to 12 ml in one liter of gel formulation is applied directly to a skin surface area having a burn or other dermal lesion to protect the area from bacterial contamination.
    Type: Grant
    Filed: June 24, 2002
    Date of Patent: February 17, 2004
    Assignee: Aqua Med, Inc.
    Inventor: John D. Young
  • Patent number: 6689392
    Abstract: A composition for controlling growth of pathological organisms on a plant, said composition comprises an effective amount of one or more of metal ion(s); one or more of chelating agent(s); and phosphorous acid, and/or salt or hydrate thereof, said composition is in an agriculturally compatible carrier or vehicle.
    Type: Grant
    Filed: January 29, 2002
    Date of Patent: February 10, 2004
    Assignee: Agricare Ltd.
    Inventor: Ran Lifshitz
  • Patent number: 6685969
    Abstract: Ectoparasites, such as fleas, ticks, mites and lice, are removed from a human or animal host after applying a composition that causes the temperature of the treated area to become higher or lower than normal. In one embodiment, treatment is effected by applying a composition that releases heat when contacted with water. The elevated or decreased temperature immobilizes the parasites and facilitates their mechanical removal, such as by combing.
    Type: Grant
    Filed: June 11, 2001
    Date of Patent: February 3, 2004
    Assignee: Schering-Plough HealthCare Products, Inc.
    Inventors: Kurt G. Van Scoik, Marcia S. Schlesinger
  • Patent number: 6652840
    Abstract: A composition is disclosed which has been shown to stop or control bleeding and seal open small blood vessels while accelerating the healing process of abraded oral “gum” and other “skin” (epithelial) tissues. The composition is preferably in the form of a paste which promotes ease of application and use of the composition. A variety of instruments can be used in application and cleanup of the composition showing versatile unparalleled friendly usage. The composition preferably comprises aluminum chloride, ferric sulfate (subsulfate), regenerated oxidized cellulose, aluminum ammonium sulfate, absorbable gelatin and a solvent. The composition has many dental and medical procedure applications.
    Type: Grant
    Filed: February 8, 2002
    Date of Patent: November 25, 2003
    Inventor: Terence Prevendar
  • Patent number: 6641825
    Abstract: A gentle skin cleansing gel is provided containing as an ingredient, water soluble salts having a negative enthalpy in solution, which when mixed with water release heat which improves the cleansing effect and the release of perfumes creating a pleasant effect on the skin.
    Type: Grant
    Filed: August 30, 2002
    Date of Patent: November 4, 2003
    Assignee: Henkel Kommanditgesellschaft auf Aktien
    Inventors: Wolfhard Scholz, Katrin Meyer zu Schlochtern-Maric, Armin Wadle
  • Patent number: 6576594
    Abstract: A method of controlling algae in a municipal water plant including the step of adding an algicide-flocculant solution including 25-50 wt % acidic flocculent, 0-10 wt % polymer flocculant aid, an algicide consisting essentially of copper having a concentration of 0.025-1.275 wt % in the form of a water soluble copper salt, balance water. The algicide-flocculant solution may be added to the water via a clarifier of the water plant, a basin of the water plant, or a mixing chamber. The mixing chamber may be located within the clarifier, adjacent to the basin, or upstream of the clarifier and/or the basin.
    Type: Grant
    Filed: June 18, 2001
    Date of Patent: June 10, 2003
    Assignee: Bay Chemical and Supply Company
    Inventors: Thomas J. Nier, Tosby L. Linn
  • Patent number: 6541038
    Abstract: A method for treating wood, characterized by impregnating wood with a metal-containing treating agent containing lignin and/or lignin derivatives and a metal, a metal compound, and/or a metal ion and oxidizing and/or macromolecularizing of the lignin and/or lignin derivatives in the wood to fix the metal component in the wood, and wood and woody materials obtained by the treating method. According to the method of the present invention, while effectively utilizing lignins, lignosulfonic acids, or lignosulfonic acid salts, leaching of the metal component can be suppressed to a low level to thereby retain the effects due to the incorporation of the metal components for a prolonged period.
    Type: Grant
    Filed: May 25, 2000
    Date of Patent: April 1, 2003
    Assignee: SDS Biotech K.K.
    Inventors: Keijitsu Tanaka, Hirobumi Aoki, Takashi Echigo
  • Patent number: 6468518
    Abstract: Animal enclosures such as poultry houses generate high amounts of ammonia that adversely affect weight gain and mortality or the animals, particularly among young chicks. The addition of a deliquescent salt, such as calcium chloride, to alum to treat animal waste products rapidly activates the alum to remove ammonia from the atmosphere. The ammonia sulfate by-product is useful as a nitrogen fertilizer.
    Type: Grant
    Filed: February 8, 2001
    Date of Patent: October 22, 2002
    Assignee: General Chemical Corporation
    Inventors: Christopher Bruce Lind, Joseph Lewis Hurd, Russell Hayden Barnes
  • Patent number: 6420312
    Abstract: An algicide-flocculant solution for use in treating raw water in a municipal water plant to control algae, the algicide-flocculant solution including 25-50 wt % of an acidic flocculant, 0-10 wt % of a polymer flocculant aid, an algicide of essentially copper having a concentration of 0.025-1.25 wt % in the form of a water soluble capper salt, and balance water. Uniform mixing of the flocculant into the raw water simultaneously uniformly mixes the algicide of the algicide-flocculant solution into the raw water. The acidic flocculant is preferably aluminium sulfate, iron sulfate, iron chloride or mixtures thereof. The water soluble copper salt is preferably copper sulfate, copper chloride, copper nitrate, copper acetate or mixtures thereof. Moreover, the flocculant aid is a high molecular weight quaternary amine such as diallyldimethylammonium chloride.
    Type: Grant
    Filed: June 11, 2001
    Date of Patent: July 16, 2002
    Assignee: Bay Chemical and Supply Company
    Inventors: Thomas J. Nier, Tosby L. Linn
  • Patent number: 6416790
    Abstract: The concentrate is a liquid mixture of about 1000 parts by volume of ultra pure water having an electrical resistance of 16-26 megohms, total dissolved solids of less than 0.04 parts per million and a specific conductance of less than 0.10 microhmo to about 1.2 to 3 parts by volume of Willard Water as prepared in accordance with U.S. Pat. No. 3,893,943. The liquid concentrate is applied directly to a skin surface area having a burn or other dermal lesion to protect the area from bacterial contamination.
    Type: Grant
    Filed: March 13, 2000
    Date of Patent: July 9, 2002
    Assignee: Aqua Med, Inc.
    Inventor: John D. Young
  • Patent number: 6350474
    Abstract: The invention deals with phosphate water solution with cold solidification capacity. Phosphate composition containing iron oxide solution in acid, water, advantages from the following properties; it contains orthophosphorus acid and in addition metal powder. Phosphate composition is ecologically pure product, non toxic, non cancerogenic, non-allergic. It has antimicrobial, antivirus and fungicidal properties. Phosphate composition can be applied within medicine: surgery, dermatology, dentistry, oncology, pharmacology and other branches. In agriculture use: as a means of curing plant diseases, within veterinary—as a means for preventive maintenance and curing of animal diseases, within construction—as an anticorrosive, fire-resistant, hydro-electric isolating covers, ceramic tiles, concretes, which protect against radiation, as well as for producing other composite materials.
    Type: Grant
    Filed: June 7, 1999
    Date of Patent: February 26, 2002
    Inventors: David Dzneladze, Andro Dzneladze, Nargisa Jabishvili
  • Patent number: 6346240
    Abstract: A method of treating liquid animal manure comprising contacting a manure slurry with a treatment composition comprising a treatment effective amount of AlCl3.nH2O or Al(NO3)3.mH2O, or the residue of AlCl3.nH2O or Al(NO3)3.mH2O, to form a resulting slurry, wherein n is from 0 to 10, and m is from 0 to 12. The treatment effective amount is effective to reduce phosphorus solubility in the manure; reduce phosphorus runoff and/or phosphorus leaching from fields fertilized with manure; inhibit ammonia volatilization from the manure; flocculate solids in the manure; reduce pathogens in the manure; increase the nitrogen content in the manure; and/or reduce acid rain and PM-10s associated with the manure.
    Type: Grant
    Filed: October 22, 1998
    Date of Patent: February 12, 2002
    Assignees: The United States of America as represented by the Secretary of Agriculture, The Board of Trustees of the University of Arkansas
    Inventor: Philip A. Moore, Jr.
  • Publication number: 20010009682
    Abstract: This invention relates to disinfectant concentrates having improved biocidal activity containing an aldehyde, such as glutaraldehyde, a glycol and a lithium based buffer.
    Type: Application
    Filed: August 13, 1999
    Publication date: July 26, 2001
    Applicant: L'OREAL
    Inventor: REGINALD KEITH WHITELEY
  • Patent number: 6248369
    Abstract: A water soluble copper salt, preferably cupric sulfate pentahydrate, is mixed with water. A small quantity of an acidic flocculant is added to the copper sulfate solution to acidify the water and promote dissolving of the copper sulfate in the water. A 25-50% water solution of an acidic flocculant, with or without a cationic polymeric flocculant aid, is prepared and pumped into a processing vessel or tank. The acidified copper sulfate solution is added to the tank and mixed with the acidic flocculant. The algicide-flocculant solution is transported to a municipal water plant and added to raw water in the clarifier to drop out particulates in the incoming water and control algae in the clarifier.
    Type: Grant
    Filed: April 6, 1998
    Date of Patent: June 19, 2001
    Assignee: Bay Chemical and Supply Company
    Inventors: Thomas J. Nier, Tosby L. Linn
  • Patent number: 6027730
    Abstract: Novel herpes simplex (HSV) vaccine formulations are provided. These comprise HSV glycoprotein gD or immunological fragments in conjunction with 3 Deacylated monophosphoryl lipid A.
    Type: Grant
    Filed: September 9, 1994
    Date of Patent: February 22, 2000
    Assignee: Smithkline Beecham Biologicals
    Inventors: Myriam Francotte, Jean-Paul Prieels, Moncef Slaoui, Nathalie Marie-Josephe Claude Garcon-Johnson
  • Patent number: 6020005
    Abstract: A genital wart treatment for treating and removing genital warts. The genital wart treatment includes the acts of dissolving a volume of particulate potassium permanganate in a volume of water to form a treatment solution, and repeatedly performing over a duration of time a treatment application comprising the acts of applying the treatment solution on to genital warts and surrounding skin of a subject to wet the genital warts and surrounding skin with the treatment solution, applying a styptic to the wet genital warts and surrounding skin, and then removing an outermost layer of skin on the genital warts.
    Type: Grant
    Filed: April 8, 1999
    Date of Patent: February 1, 2000
    Inventor: Ervin G. Weathers
  • Patent number: 6001348
    Abstract: The present invention provides NAD-independent Mycoplasma synoviae of strain MS1. The invention also refers to microbiological cultures comprising Mycoplasma synoviae of this strain. Next to this, the invention refers to live vaccines derived from these strains, for the protection of poultry against Mycoplasma synoviae infection. Furthermore, the invention provides methods for the preparation of such vaccines. Also, the use of NAD-independent Mycoplasma synoviae strains for the preparation of live vaccines for the protection of poultry against Mycoplasma synoviae infection is disclosed.
    Type: Grant
    Filed: December 5, 1997
    Date of Patent: December 14, 1999
    Assignee: Akzo Nobel N.V.
    Inventor: Maarten Hendrik Witvliet
  • Patent number: 5961968
    Abstract: A method for treating poultry litter which inhibits ammonia volatilization and reduces soluble phophorus levels in the litter. The method comprises the addition of alum to litter in an amount sufficient to maintain the litter pH at values low enough to inhibit ammonia volatilization. The addition of alum, iron or calcium compounds to litter also effectively precipitates soluble phosphorus in litter, thereby reducing the amount of soluble phosphorus runoff from fields receiving litter.
    Type: Grant
    Filed: May 1, 1996
    Date of Patent: October 5, 1999
    Assignees: Trustees of University of Arkansas, The United States of America as represented by the Secretary of Agriculture
    Inventor: Philip A. Moore, Jr.
  • Patent number: 5955112
    Abstract: A non-stinging styptic composition in the form of a water soluble resin coated cast pencil, for stopping bleeding from cuts and nicks received during shaving. The composition comprises aluminum sulfate, aloe, glycerine, lidocaine and polyethylene glycol 400.
    Type: Grant
    Filed: February 11, 1998
    Date of Patent: September 21, 1999
    Inventor: Jeffrey Kaplan